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Abstract
Background: Consumption of virgin olive oil (VOO) has been associated with a low breast cancer incidence.
Pinoresinol is a phytoestrogen that is typically found in VOO. Considering the role of oestrogen in breast cancer
development and progression, we investigated the potential antitumor activity of pinoresinol in breast cancer cells.
Methods: To address this question, we treated MDA-MB-231 (oestrogen receptor [ER] negative) and MCF7 (ER+)
human breast tumour cells and MCF10A human mammary epithelial cells (ER-) with different concentrations of
pinoresinol. The cytotoxic activity, cell proliferation, cell cycle profile, apoptosis induction, reactive oxygen species
production and DNA damage were assessed.
Results: Pinoresinol showed cytotoxic, anti-proliferative and pro-oxidant activity in human breast tumour cells,
independent of their oestrogen receptor status. In addition, pinoresinol exerted antioxidant activity and prevented
DNA damage associated with oxidative stress in human mammary epithelial cells.
Conclusions: Overall, the results suggest that pinoresinol may have antitumor activity in human breast cancer cells
independently of oestrogen receptor status. Furthermore, the results show that the pinoresinol has the typical
characteristics of a chemopreventive compound.
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Background
Growing scientific evidence suggests that the intake of vir-
gin olive oil (VOO), which is the main source of fat in
Mediterranean diets, correlates with a low incidence of
breast cancer [1]. Among the minor compounds present in
VOO that possess different health properties [2–6], we find
polyphenols to be a very interesting group because of their
biological benefits. It has been reported that polyphenols
prevent the development and progression of pathological
conditions, such as cancer, neurological and cardio-vascular
diseases, diabetes, aging, and so on [7].
One of the most abundant phenolic compounds in
VOOs, behind tyrosol and hydroxytyrosol, is
(+)-pinoresinol (PINO) [8] (Fig. 1). Its presence in VOOs
depend on the variety of the cultivar, in amounts of 0.07 ±
0.003 mg/kg in Arbequina variety, about 0.90 ± 0.78 in
Picual variety [9]. Brenes et al. [10] reported that Spanish
olive oil contains a range of 20 to 45 mg/kg PINO. Several
health properties have been attributed to PINO, including
antifungal [11], anti-inflammatory [12, 13], hypoglycaemic
[14] or chemopreventive biological activities [15, 16].
PINO has a chemical structure that is similar to that of
oestrogen (i.e., it is a phytoestrogen). Oestrogen is essen-
tial for the growth and development of mammary glands
and has been linked with the development and progres-
sion of breast cancer due to enhanced binding and activa-
tion of the oestrogen receptor α (ERα) [17]. For example,
the phytoestrogen tamoxifen acts as an oestrogen antag-
onist in breast tissue and has been shown to slow breast
cancer cell proliferation and has been used in clinical
practice for breast cancer patients [18].
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Interestingly, ERβ has also been shown to mediate es-
trogenic action. The specific role of this receptor in hu-
man breast cancer remains elusive; however, in contrast
to ERα, ERβ has been linked with anti-proliferative and
pro-apoptotic activities. In fact, the expression of ERβ is
lower in human breast cancer cells compared to normal
breast cells, supporting its potential tumour-suppressive
role [19].
Surprisingly, very few studies have noted the role of
PINO as a potential agonist or antagonist of oestrogen
and the chemopreventive repercussions that PINO treat-
ment may have on hormone-related breast cancer [20].
The chemical antioxidant activity of PINO also re-
mains unclear. A few studies using DPPH and ABTS as-
says have shown different antioxidant functions of PINO
[21-23]. However, the Oxygen Radical Absorbance Cap-
acity method (ORAC) has not been used in past studies,
despite being considered one of the most biologically
relevant assays [24].
Furthermore, the little research that has been done
surrounding the effects of this compound on breast can-
cer cells remains inconclusive. Chin et al. [21] described
a lack of cytotoxic effects and a cytoprotective effect of
PINO on MCF7 cells stressed by H2O2 [25]. Other au-
thors have reported anticancer effects of PINO by sup-
pressing the expression of the lipogenic enzyme FASN
in HER-2 overexpressing MCF7 cells [26]. Recently,
Sepporta et al. [27] observed that PINO inhibited the
growth of MDA-MB-231 cells, but not of MCF7 cells.
Importantly, no previous study has examined the effects
of PINO on a normal human breast cell line, which
would address whether PINO plays a protective role
against cancer development.
Therefore, the aim of the present study was to exam-
ine whether PINO exerts chemopreventive and/or anti-
tumor activity in breast cancer, specifically because this
compound is found in VOO and its consumption has
been related with a minor incidence of breast cancer.
Therefore, to determine whether this compound may
contribute, at least in part, to the health benefits attrib-
uted to VOO on breast cancer incidence and mortality,
we studied the effects of PINO on breast cells with dif-
ferent receptor expression patterns. For this purpose, we
used the following human mammary cells: highly inva-
sive MDA-MB-231 (oestrogen receptor [ER] and proges-
terone receptor [PR] negative) breast tumour cells, the
minimally invasive MCF7 (ER and PR positive) breast
tumour cells and MCF10A human mammary epithelial
cells (ER and PR negative).
Methods
Chemicals and material
The following were purchased from Gibco® Life Tech-
nologies Ltd (Paisley, UK): HuMEC Ready Medium
(1X), TrypLE™ Express Enzyme (1X) and Minimum
Essential Medium (MEM). Foetal bovine serum (FBS)
was obtained from PAA Laboratories GmbH (Pasch-
ing, Austria). Ethanol 96 % v/v and potassium perox-
odisulfate (K2S2O8) (CAS 7727-21-1) were purchased
from Panreac Química S.L.U. (Barcelona, Spain). The
CellTiter-Blue® Cell Viability Assay was acquired from
Promega Corporation (Madison, WI, USA). Round
bottom culture plates and cell culture flasks were
purchased from Nunc A/S (Roskilde, Denmark). Flat
bottom culture plates were from CytoOne (Hamburg,
Germany). Fluorescein (FL) (CAS 2321-07-5) was ob-
tained from Life Technologies (Carlsbad, CA, USA).
The following were obtained from Sigma-Aldrich Co.
(St. Louis, MO, USA): (+)-Pinoresinol (CAS 487-36-5)
purity ≥95 %; PBS; (S)-(+)-camptothecin (CPT) (CAS
7689-03-4) purity ≥90 %; 2′,7′-dichlorofluorescin dia-
cetate (DCFH-DA) (CAS 4091-99-0) purity ≥97 %;
Sodium pyruvate solution (CAS 113-24-6); MEM
Non-essential Amino Acid Solution (NEAA); HEPES
buffer solution (CAS 7365-45-9); 2,2-Diphenyl-1-
picrylhydrazyl (DPPH) (CAS 1898-66-4); 2,2′-Azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) diammo-
nium salt (ABTS) (CAS 30931-67-0) purity ≥98 %;
(±)-α-Tocopherol (Vitamin E) (CAS 10191-41-0) pur-
ity ≥96 %; (±)-6-Hydroxy-2,5,7,8-tetramethylchro-
mane-2-carboxylic acid (Trolox™) (CAS 53188-07-1)
purity 97 % and 2,2′-Azobis (2-methylpropionami-
dine) dihydrochloride (AAPH) (CAS 2997-92-4) purity
97 %. PBS (1X, Dulbecco’s) and DMSO (CAS 67-68-
5) were obtained from AppliChem GmbH (Darmstadt,
Fig. 1 Chemical structure of (+)-pinoresinol
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Germany). The PI/RNase Staining Buffer kit, Annexin
V-FITC kit and Comet Assay kit (CAS 50-07-7) were
purchased, respectively, from BD Biosciences, Phar-
mingen (San Diego, CA), Miltenyi Biotec (Bergisch
Gladbach, Germany) and Trevigen, Inc. (Gaithersburg,
MD, USA). Non-tumorigenic human breast epithelial
cells (MCF10A), minimally invasive human breast
cancer cells (MCF7) and highly invasive human breast
cancer cells (MDA-MB-231) were obtained from
American Type Culture Collection (ATCC, Manassas,
VA, USA).
ABTS radical scavenging test
The ABTS radical scavenging activity was measured as
previously reported [28]. ABTS radical cations (ABTS●+)
were produced by reacting 7 mM ABTS with 2.45 mM
K2S2O8 (final concentration) for 16 h in the dark at
room temperature. The radical obtained was diluted in
ultrapure water until the absorbance at 734 nm was be-
tween 0.7 and 1. Ethanol solutions of Trolox™ (antioxi-
dant standard) or pinoresinol (PINO) were diluted in
ultrapure water to reach concentrations between 50 and
800 μM and 0.00001 and 1000 μM, respectively. Twenty
microliters of each concentration of Trolox™, PINO, ul-
trapure water (blank) or ethanol control (10 %) were
added into a flat bottom 96-well plate. The reaction was
initiated by the addition of 50 μL of ABTS●+, and the ab-
sorbance at 734 nm was immediately measured every
5 min over 2 h at 30°C with a TECAN GENios Plus mi-
croplate reader (Tecan Group Ltd., Switzerland). All of
the reactions were performed in triplicate, in three inde-
pendent experiments. The percentage of the radical
scavenging activity (% RSA) was calculated according to
the following formula:
% RSA ¼ 100 AC 0ð Þ– AA tð Þ
 
=AC 0ð Þ ð1Þ
where AC(0) is the absorbance of the blank at t = 0 and
AA(t) is the absorbance of the compound/standard at t = 60.
Radical scavenging activity by the DPPH assay
Estimation of the antioxidant capacity against the radical
DPPH was carried out according to Brand-William
et al., [29] with some modifications. An ethanolic solu-
tion of DPPH 100 μM (final concentration) was mixed
in 96-well plates with ethanolic solutions of PINO or α-
tocopherol (antioxidant standard) at 0.03, 0.06, 0.13,
0.25, 0.5, 1 and 2 mole ratios (moles of antioxidant/
moles of DPPH). DPPH samples without antioxidants
were also measured as blank controls. The absorbance at
520 nm was read every 5 min over 2 h with a TECAN
GENios Plus microplate reader. Measurements were per-
formed at least in triplicate in three separate
experiments. The radical scavenging activity (% RSA)
was calculated as described in Eq. (1) (t = 60).
ORACFL assay
The Oxygen Radical Absorbance Capacity (ORAC) of
PINO was assayed as described in Prior et al. [30]. This
method measures the oxidative degradation of fluorescein
induced by the thermal decomposition of the AAPH azo-
compound. In brief, fluorescein (48 nM) was added to each
well of a round bottom 96-well plate that was previously
tempered at 37°C. Then, PINO (from 0.001 to 1000 μM),
TroloxTM (standard, from 12.5 to 100 μM) or PBS (blank)
with a final volume of 1 % DMSO (v/v) was added to the
wells. After incubating for 15 min at 37 °C, AAPH was
added to the wells. Fluorescence readings (Ex. λ485/Em. λ520
nm) were taken every 5 min at 37 °C for 160 min with a
TECAN GENios Plus microplate reader. The final results
were calculated based on the difference in the area under
the fluorescence decay curve (AUC) between the blank and
each sample. The AUC formula was determined as follows:
AUC ¼ 1 þ f 1=f 0 þ f 2=f 0 þ f 3=f 0 þ …
þ f n=f 0 ð2Þ
where f0 is the initial fluorescence at cycle 0 and fn is
the fluorescence reading at cycle n.
The results were expressed as micromolar TroloxTM
equivalents (TE), which were calculated using the line
equation from the standard curve:
TE ¼ Y – bð Þ=m ð3Þ
where Y is the net AUC (AUCsample – AUCcontrol), b is
the Y-intercept and m is the slope.
Cell culture and treatments
Human MCF10A (ERα and PR negative) breast epithelial
cells were grown in HuMEC Ready Medium. Human
MCF7 (ERα and PR positive) and MDA-MB-231 (ERα
and PR negative) breast cancer cells were grown in
MEM supplemented with 10 % FBS, 1 % Hepes buffer,
1 % NEAA and 1 % Sodium Pyruvate. The cells were
cultivated as monolayer cultures in a humidified atmos-
phere with 5 % CO2 at 37°C and subcultured using Try-
PLE Express. Cells growing between 90 and 95 % of
confluence were used for all experiments. The cells were
treated for 24 h with 0.001, 0.01, 0.1, 1, 10 and 100 μM
of PINO that was previously dissolved in DMSO (stock
concentration 50 mM).
Cytotoxicity assay
The effects of PINO on cell viability were determined by
the CellTiter-Blue® Cell Viability Assay according to the
manufacturer’s protocol with some modifications. A
total of 5x103 cells/well (for MDA-MB-231 and MCF7)
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or 2.5x103 cells/well (for MCF10A) were seeded onto a
96-well plate. After 24 h to allow for cell attachment, the
cells were treated with PINO or DMSO (as vehicle con-
trol) for another 24 h. CellTiter-Blue® was then added,
and the plates were incubated for 3 h in darkness at 5 %
CO2 and 37°C. Finally, fluorescence was read with a
TECAN GENios Plus microplate reader (Ex. λ485/Em.
λ595 nm) and viability was calculated using the formula:
% viable cells ¼ Atreated cellsð Þ=Acontrol½  x 100 ð4Þ
where A corresponds to the relative fluorescence units
of each sample. All of the measurements were per-
formed in triplicate and each experiment was repeated
at least three independent times.
Cell proliferation assay
In all of the cell proliferation experiments performed, the
cells were seeded cells onto 96-well plates and allowed to
attach before adding PINO or DMSO as the vehicle con-
trol. After 24 h of treatments, the medium was replaced by
fresh medium and the plates were incubated for another
24 h. Then, CellTiter-Blue® was added, and fluorescence
was read after 3 h of incubation with a TECAN GENios
Plus microplate reader (Ex. λ485/Em. λ595 nm). The mea-
surements were repeated at 48, 72 and 96 h. The percent-
age of viable cells was calculated as defined in Eq. (4).
Cell cycle analysis
A total of 1 x 105 cells/mL (for MDA-MB-231 and
MCF7 cells) or 5 x 104 cells/mL (for MCF10A cells)
were seeded and allowed to attach for 24 h before treat-
ing with PINO for another 24 h. The cells were then
fixed in cold 70 % ethanol, stored at −20°C for at least
24 h and labelled with a PI/RNase Staining Buffer kit.
Cell cycle assessment was conducted by flow cytometry
in an EPICS XL-MLC flow cytometer (Beckman Coulter,
Spain), and the results were analysed using the FlowJo
program (v5.7.2). Each experiment was repeated three
independent times.
Apoptosis analysis
MDA-MB-231 (1 x 105 cells/mL), MCF7 (1 x 105 cells/
mL) or MCF10A (5 x 104 cells/mL) cells were seeded,
allowed to attach and treated for 24 h with PINO. The
cells and supernatants were collected and labelled with
Annexin V-FITC kit according to the manufacturer’s
suggestions. As a positive control, the cells were incu-
bated with 1 μM camptothecin (CPT). Apoptosis ana-
lysis was carried out using an EPICS XL-MLC flow
cytometer, and the results were analysed using the
FlowJo program. Each experiment was repeated three in-
dependent times.
Detection of reactive oxygen species
Detection of intracellular Reactive Oxygen Species (ROS)
was performed using the probe 2’, 7’-dichlorofluorescin dia-
cetate (DCFH-DA) as previously reported by our group
[31]. In brief, MCF10A (5.5x103 cells/well), MDA-MB-231
or MCF7 cells (7x103 cells/well) were seeded onto 96-
well plates, allowed to attach for 24 h and then treated
with PINO for an additional 24 h. After the addition of
DCFH-DA (100 μM), the plates were incubated for
30 min at 37 °C and 5 % CO2. Fluorescence was then
read for 30 min (Ex. λ485/Em. λ535) with a TECAN
GENios Plus microplate reader.
It is well known that the addition of H2O2 increases
stress in culture cells [32]. To test whether PINO had a
protective role against induced oxidative stress, the assay
was also performed after the addition of H2O2 (400 μM)
30 min before quantification.
Both experimental conditions were assayed three inde-
pendent times, and each measurement was performed in
quadruplicate. In all cases, iron free media (MEM or
HuMEC) were used.
The intracellular ROS level percentage was calculated
as follows:
F ¼ Ft30–Ft0ð Þ=Ft0½  x 100 ð5Þ
where Ft0 is the fluorescence at t = 0 min and Ft30 the
fluorescence at t = 30 min.
Alkaline single-cell gel electrophoresis (Comet assay)
To estimate the state and wholeness of DNA, 5x104 cells/
well (for MCF10A cells) or 1x105 cells/well (for MCF7 and
MDA-MB-231 cells) were allowed to attach to a 12-well
plate and treated with increasing PINO concentrations for
24 h. The cells were then detached and centrifuged twice in
PBS. To evaluate whether PINO had the ability to protect
against oxidative DNA damage, cells were also exposed to
H2O2. The comet assay was carried out according to
Warleta et al. [3]. Analysis of the DNA strands was per-
formed by examining twenty-five random cell images per
sample in a Zeiss Axioplan 2 epifluorescence microscope
(Carl Zeiss; Jena, Germany) equipped with Luca EMCCD
camera (Andor Technology, Belfast, UK) and using the
Komet 5.5 software package (Kinetic Imaging Ltd., Liver-
pool, UK). DNA damage was calculated by determining the
relative fluorescence between the head and tail using the
olive tail moment (Olive_TM), which was defined as:
OliveTM ¼ tail meanð Þ – head meanð Þð Þ x tail % DNAð Þ½ =100
ð6Þ
Statistical analysis
Statistical analyses were performed using one-way ana-
lysis of variance (ANOVA) followed by Fisher’s LSD test
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with the STATGRAPHICS Centurion XVI software
(Statpoint Technologies, Inc. Warrenton, VA, USA). The
values of p < 0.05 were considered significant. The data
are represented as the mean of at least three independ-
ent experiments ± SEM and are expressed relative to the
untreated controls.
Results
ABTS radical scavenging test
The radical cation ABTS●+ was diminished by pinoresi-
nol (PINO) above 10 μM (Fig. 2), and the studied range
was from 0.00001 to 1000 μM. Concentrations lower
than 10 μM did not shown antioxidant capacity (data
not shown). The antioxidant effects of PINO were
higher than the antioxidant standard, as the 50 % of
Radical Scavenging Activity (RSA) occurred at 380 μM
for Trolox™ and at 274 μM for PINO.
Radical scavenging activity by the DPPH assay
As depicted in Fig. 3, PINO exhibited antioxidant activity
against the DPPH radical in a dose dependent manner. The
RSA of PINO was determined to be 50 % at 0.69 mol ratio
Fig. 2 ABTS radical scavenging assay. ABTS●+ radical scavenging activity of (+)-pinoresinol a or TroloxTM b at concentrations between 0.01and
1000 μM and 50 and 800 μM, respectively. Data are expressed as the absorbance of ABTS●+, which was read at 734 nm for 2 h. Measurements
were performed in triplicate in three independent experiments
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(69 μM), while the RSA of the antioxidant control α-
tocopherol was 50 % at 0.11 mol ratio (11 μM).
ORACFL assay
The peroxyl radical scavenging activity of PINO, as mea-
sured by ORACFL, showed a protective effect against
AAPH-induced peroxyl radical activity. PINO exerted a
higher protection than Trolox™. The micromolar Tro-
loxTM equivalents (TE) values were 39.95, 64.93, 114.89
and 214.81 for 12.5, 25, 50 and 100 μM of PINO.
Cytotoxicity assay
To assess the potential cytotoxic effects of PINO, MDA-
MB-231, MCF7 and MCF10A cells were treated with
concentrations of PINO ranging from 0.001 to 100 μM for
24 h. Surprisingly, PINO treatment was shown to promote
a widespread cytotoxic effect at low concentrations in
MCF7 cells and at all of the concentrations tested in
MDA-MB-231 cells, although statistically significant
changes were only observed from 0.001 to 1 μM (Fig. 4).
Importantly, the percentage of non-tumorigenic human
mammary epithelial cells death following treatment with
0.001 μM PINO was much lower (10 %) than in breast
cancer cells (29 % for MDA-MB-231 and 20 % for MCF7
cells). In addition, a 10 μM PINO dose was shown to
inhibit proliferation in MCF7 cells but did not induce sig-
nificant cytotoxicity in MCF10A. Interestingly, a statisti-
cally significant cytotoxic effect was observed following
Fig. 3 DPPH radical scavenging assay. Antioxidant activity of (+)-pinoresinol a against DPPH radicals at 0.03, 0.06, 0.13, 0.25, 0.5, 1 and 2 mole
ratios (mol antioxidant/mol DPPH). α-tocopherol b was used as the antioxidant control at the same ratios. Data represents the absorbance of
DPPH radicals read at 520 nm for 2 h. Each experiment was performed in triplicate and repeated three times
López-Biedma et al. BMC Complementary and Alternative Medicine  (2016) 16:350 Page 6 of 14
0.01 μM PINO treatment in both types of human breast
tumour cells tested, but not in human mammary epithelial
cells.
Cell proliferation
Proliferation of MDA-MB-231 (Fig. 5a), MCF7 (Fig. 5b)
and MCF10A cells (Fig. 5c) was determined after treat-
ment with PINO for 24 h followed by incubation with
fresh medium. Measurements were performed at 24, 48,
72 and 96 h following treatment removal. At 0.001, 0.01
and 0.1 μM, cell survival was inhibited in MDA-MB-231
and MCF7 cells. Surprisingly, at 0.001 μM, proliferation
was reduced in tumour cells, but not in mammary epi-
thelial cells, in a statistically significant manner. Strong
proliferation was observed in MCF10A cells treated with
up to 100 μM PINO, whereas neither MDA-MB-231 nor
MCF7 showed this effect.
Analysis of cell cycle and apoptosis
PINO treatment did not produce cell cycle alter-
ations in the three cell lines studied, with the excep-
tion of the 100 μM concentration, which diminished
the percentage of cells in the S phase in a statisti-
cally significant manner (Table 1). This percentage
was 8.34 ± 0.94 vs. 17.01 ± 2.33 of the control for
MDA-MB-231 (a decrease of 50.97 % respect to the
control), 11.96 ± 0.68 vs. 16.72 ± 0.86 for MCF7 (de-
crease of 28.47 %) and 9.92 ± 1.02 vs. 20.96 ± 1.29 for
MCF10A (decrease of 52.67 %). PINO also increased
the percentage of cells in G0/G1 for MDA-MB-231
(73.39 ± 1.69 vs. 60.67 ± 4.8 of the control, i.e., in-
crease of 20.97 %) and MCF10A cells (76.1 ± 2.01 vs.
56.45 ± 0.2, that is, 34.81 % of increase respect to
the control) and decreased the percentage of cells in
47.24 % in the G2/M phase in MCF10A cells (9.45 ±
2.1 vs. 17.91 ± 1.08 of the control). Unfortunately,
100 μM concentrations are not considered to be
physiologically relevant. Representative cell cycle his-
tograms of MDA-MB-231, MCF7 and MCF10A cells
treated with PINO are shown in Additional file 1.
Statistically significant levels of apoptosis were induced
in MCF10A cells treated with 100 μM PINO, with an in-
crement of 445.86 % respect to the control (7.26 ± 2.54 vs.
1.33 ± 0.42) (Table 2). An increase of 19.72 % in apoptosis
and 42.98 % in cell death, albeit not statistically significant,
also appeared in MDA-MB-231 cells treated at this con-
centration (18.46 ± 5.92 vs. 14.82 ± 4.76 and 3.42 ± 1.09 vs.
1.95 ± 0.6, respectively). No significant pro-apoptotic ef-
fects of PINO were reported in MCF7 cells. Additional file
2 represents the flow cytometry analysis of MDA-MB-231,
MCF7 and MCF10A cells after treatment with PINO.
DCFH-DA
Reactive Oxygen Species (ROS) were measured using
the DCFH-DA method under basal conditions (Fig. 6a)
and after oxidative stress induced by H2O2 (Fig. 6b). In
the basal state, 10 and 100 μM concentrations of PINO
were shown to diminish ROS levels in a statistically sig-
nificant way in MCF10A and MDA-MB-231 cells,
whereas all concentrations of PINO decreased ROS
levels in MCF10A cells (Fig. 6a). Under conditions of
oxidative stress (Fig. 6b), the presence of ROS was in-
creased in breast cancer cell lines, especially MCF7 cells,
with statistically significant levels observed at 1, 10 and
100 μM in MCF7 cells and at 100 μM in MDA-MB-231
cells. Importantly, increased ROS production was not
observed in PINO-treated human mammary epithelial
cells (MCF10A).
Comet assay
The percentage of DNA damage was determined by alka-
line single-cell gel electrophoresis and expressed as Oli-
ve_TM. Data were expressed as the percentage relative to
the basal (untreated) control, which was set as 100 %. For
MDA-MB-231 cells (Fig. 7a), DNA was injured by PINO
under basal conditions at 0.1, 1 and 100 μM, but was pro-
tected after additional stress with H2O2. For MCF7 cells
(Fig. 7b), treatment with PINO tended to increase DNA
damage with respect to both the untreated control and
H2O2-treated control; however, statistically significant
changes were only observed at 100 μM. Finally, PINO
treatment was shown to have more of a protective effect
in MCF10A cells (Fig. 7c) treated with H2O2 compared to
the basal state. Indeed, a statistically significant reduction
in DNA damage (93 %) was observed at 1 μM. Fig. 7d
shows representative comet assay images of MDA-MB-
231, MCF7 and MCF10A cells under different conditions.
Fig. 4 Cytotoxicity assay. Cell survival measured by CellTiter-Blue®
after 24 h of (+)-pinoresinol treatment on MDA-MB-231, MCF7 and
MCF10A cells. Data are represented as the treatment average (±SEM)
with respect to the control, which was considered as 100 %, for
three independent assays carried out in triplicate. * MDA-MB-231, †
MCF7 and Δ MCF10A indicate statistically significant differences
at p < 0.05
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Discussion
As early as 1980s, it was suggested that lignans might pre-
vent breast cancer and that this effect might be correlated
with their phytoestrogenic activity. In addition, consump-
tion of VOO, which contains significant amounts of lig-
nans (e.g., PINO and 1-acetoxypinoresinol) as the major
Fig. 5 Cell proliferation. Cell proliferation was measured by CellTiter-Blue® after 24 h of (+)-pinoresinol treatment followed by proliferation periods
of 24, 48, 72 and 96 h in MDA-MB-231 (a), MCF7 (b) and MCF10A (c) cells. Data are represented as the mean (±SEM) with respect to the controls,
which were set as 100 %, for three independent assays carried out in triplicate. *, † and Δ denote statistically significant differences relative to the
control at p < 0.05 for MDA-MB-231, MCF7 or MCF10A, respectively
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Table 1 Percentage of cell cycle phases was measured by flow cytometry after treatment with PINO
MDA-MB-231 MCF7 MCF10A
SubG0/G1 G0/G1 S G2/M SubG0/G1 G0/G1 S G2/M SubG0/G1 G0/G1 S G2/M
Control 1.72 ± 0.3 60.67 ± 4.8 17.01 ± 2.33 20.59 ± 2.46 0.69 ± 0.11 61.57 ± 0.19 16.72 ± 0.86 21.00 ± 0.74 1.23 ± 0.17 56.45 ± 0.2 20.96 ± 1.29 17.91 ± 1.08
0.001 μM 2.57 ± 0.7 60.87 ± 3.37 16.75 ± 1.68 20.23 ± 2.56 0.54 ± 0.03 62.71 ± 0.23 16.70 ± 0.43 20.60 ± 0.73 1.86 ± 0.7 55.32 ± 1.43 22.44 ± 0.34 16.77 ± 1.02
0.01 μM 1.80 ± 0.21 59.16 ± 4.53 17.55 ± 2.68 20.71 ± 2.01 0.62 ± 0.14 61.64 ± 1 16.72 ± 0.25 21.58 ± 0.93 1.67 ± 0.42 54.12 ± 2.3 21.79 ± 0.62 17.36 ± 1.47
0.1 μM 1.32 ± 0.24 59.33 ± 4.15 18.92 ± 1.68 20.35 ± 2.38 0.49 ± 0.02 60.71 ± 0.51 18.41 ± 0.5 20.61 ± 0.64 1.45 ± 0.22 54.84 ± 1.19 20.47 ± 0.53 19.09 ± 1.1
1 μM 1.62 ± 0.29 60.63 ± 4.93 18.56 ± 2.45 19.37 ± 2.48 0.49 ± 0.03 62.99 ± 1.28 16.99 ± 0.62 20.12 ± 1.06 1.85 ± 0.25 54.72 ± 0.65 21.23 ± 0.8 17.58 ± 1.16
10 μM 1.76 ± 0.3 64.85 ± 4.74 17.6 ± 2.38 15.52 ± 2.21 0.57 ± 0.03 61.73 ± 0.65 18.08 ± 0.41 19.62 ± 0.73 1.66 ± 0.12 53.93 ± 1.54 20.23 ± 1.1 19.6 ± 0.84
100 μM 2.29 ± 0.44 73.39 ± 1.69a 8.34 ± 0.94a 16.06 ± 1.8 0.81 ± 0.19 63.92 ± 1.13 11.96 ± 0.68a 23.38 ± 0.85 1.26 ± 0.23 76.1 ± 2.01a 9.92 ± 1.02a 9.45 ± 2.1a



















components of its phenolic fraction, has been correlated
with a low occurrence of breast cancer [1]. In fact, in the
phenolic fraction of VOOs there are several compounds
with anti-breast cancer properties as oleouropein [33],
hydroxytyrosol and tyrosol [6]. Certain compounds showed
more effectiveness in ER- breast cancer cells than in ER+
breast cancer cells [33]. PINO and 1-acetoxypinoresinol
were first detected in VOO by Owen et al. [8] and differ in
their relative amounts according to the different olives var-
ieties used to make the VOO [9]. For example, Brenes et al.
[10] reported that Spanish olive oil contains a range of 20
to 45 mg/kg PINO. Despite the well-established preventa-
tive role of phytoestrogens against breast cancer, very little
research has been done to elucidate whether PINO plays a
chemopreventive role or exhibits antitumor activity in hu-
man breast cancer cells. Moreover, the oestrogen receptor
status is a key factor to consider in breast cancer therapy.
In fact, hormone therapy is only used in oestrogen
receptor-positive breast cancer [17, 18]. Accordingly, we
attempted to elucidate the effects of PINO on human
mammary cells with different oestrogen and progesterone
receptor expression, to determine whether this compound
may contribute, at least in part, to the reduced incidence of
breast cancer associated with VOO consumption. For this
purpose, we used the following human breast tumour cells:
MDA-MB-231 cells (ER-, PR-) and MCF7 cells (ER+, PR
+). Furthermore, non-tumorigenic human mammary epi-
thelial cells were also used in the present study [MCF10A
(ER-, PR-)].
Our results, summarized in Table 3, indicate that
PINO showed cytotoxic, anti-proliferative and pro-
oxidant activity in human breast tumour cells, independ-
ent of their oestrogen receptor expression levels. In
addition, based on its effect in human mammary epithe-
lial cells (Table 3), PINO may have chemopreventive ac-
tivity, as induced antioxidant activity and prevented
DNA from oxidative damage at a concentration of
1 μM. Interestingly, we found that PINO exerted differ-
ential activity on human breast tumour cells compared
with mammary epithelial cells. Indeed, PINO treatment
induced antioxidant activity in mammary epithelial cells,
while it acted as a pro-oxidant molecule in human breast
cancer cells after inducing oxidative stress.
The cytotoxic activity of PINO on human breast
tumour cells is a debated issue. Previously, Chin et al.
[25] described that PINO has a cytotoxic effect against
MCF7 breast cancer cells (ED50 = 4.74 μM); however, in
a later article [21], the same author found no cytotoxic
effects. Surprisingly, the range of concentrations used in
both studies was not specified. In addition, the cytotoxic
effects of PINO in MDA-MB-231 cells have not been
previously reported. In contrast, we tested a wide range
of PINO concentrations and showed that there was cyto-
toxic activity at different concentrations in both human
breast tumour cells tested. While PINO showed cyto-
toxic activity in both types of human breast tumour cells
tested, the effect was more pronounced in negative
oestrogen receptor tumour cells compared to oestrogen
receptor-positive tumour cells (Figs. 4 and 5). In
addition, for the first time, we describe the effects of
PINO on human mammary epithelial cells. Our results
suggest that PINO ranging between 0.001 and 0.1 μM,
which could be considered as physiological doses, has a
much greater cytotoxic effect on breast tumour cells
compared to mammary epithelial cells, suggesting an
anti-tumour effect of this compound with a minor dam-
age to non-tumorigenic tissue.
Little research has been performed to understand the ef-
fects of PINO on human breast cancer cell proliferation.
Sepporta et al. [27] found that PINO inhibited the growth
of MDA-MB-231, but not of MCF7 cells; however, their
study was limited to 100 μM, which is not considered to
be a physiological concentration. In contrast, we tested a
wide range of PINO concentrations, ranging from 0.001
to 100 μM, and showed that low concentrations of PINO
elicited a significant antiproliferative effect on both human
breast tumour cell lines tested. Future work is needed to
clarify the mechanisms of inhibition of breast cancer cells
growth only at low doses.
Oestrogen has been associated with the promotion and
growth of breast cancer. In line with this result, most hu-
man breast cancers that are oestrogen-dependent undergo
Table 2 Percentage of live, apoptotic and dead cells after 24 h after exposure to PINO (0.001, 0.01, 0.1 1 10 and 100 μM)
MDA-MB-231 MCF7 MCF10A
Live Apoptotic Death Live Apoptotic Death Live Apoptotic Death
Control 83.22 ± 5.33 14.82 ± 4.76 1.95 ± 0.6 92,03 ± 2,69 6,97 ± 2,9 1,26 ± 0,61 98.14 ± 0.47 1.33 ± 0.42 0.5 ± 0.08
0.001 μM 82.17 ± 4.76 15.56 ± 5.56 2.25 ± 0.94 92,38 ± 1,82 6,2 ± 1,83 1,07 ± 0,62 96.17 ± 0.76 2.73 ± 0.48 1.08 ± 0.29
0.01 μM 80.94 ± 8.15 16.24 ± 6.77 2.8 ± 1.57 93,14 ± 2,06 5,98 ± 1,69 0,85 ± 0,42 95.7 ± 1.44 3.45 ± 1.63 0.83 ± 0.37
0.1 μM 76.84 ± 9.32 20.15 ± 8.06 2.99 ± 1.34 92,47 ± 1,33 6,49 ± 1,08 1,03 ± 0,39 95.11 ± 2.6 3.99 ± 2.56 0.88 ± 0.16
1 μM 78.82 ± 7.41 18.05 ± 6.27 3.16 ± 1.29 93,32 ± 1,98 5,86 ± 1,61 0,8 ± 0,43 93.32 ± 1.51 5.85 ± 1.76 0.8 ± 0.25
10 μM 79.33 ± 7.24 17.75 ± 6.15 2.9 ± 1.19 93,89 ± 1,29 5,4 ± 1,08 0,69 ± 0,28 95.07 ± 1.1 4.17 ± 1.3 0.74 ± 0.2
100 μM 78.1 ± 6.84 18.46 ± 5.92 3.42 ± 1.09 91,65 ± 1,25 7,48 ± 1,14 0,85 ± 0,18 91.82 ± 2.33a 7.26 ± 2.54a 0.9 ± 0.23
Values represent the average ± SEM of three independent experiments. a was considered statistically significant respect to the control (p < 0.05)
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regression when deprived of the supporting hormone [17].
Our results, therefore, are very interesting because al-
though PINO is a phytoestrogen with an oestrogen-like
chemical structure, it produced a decrease in the prolifera-
tion of human breast tumour cells. Thus, PINO could
have oestrogen antagonist activity, like tamoxifen, which
inhibits breast cancer cells proliferation. However, in the
experimental cell model we designed, we used cell culture
media without oestrogen supplementation, suggesting that
PINO is not likely to act as an oestrogen antagonist. Inter-
estingly, a previous prospective study showed that high
dietary intakes of plant lignans, such as PINO, were asso-
ciated with reduced risks of ER+/PR+ postmenopausal
breast cancer [20]. We do not believe that the anti-
proliferative effects of PINO are mediated by interactions
with ERα because this receptor is not expressed in MDA-
MB-231 breast tumour cells. Furthermore, the cell prolif-
eration reduction was higher in MDA-MB-231 cells than
in ERα +MCF7 breast cancer cells. On the other hand, it
is unlikely that the anti-proliferative effects of PINO could
be due to the activation of ERβ because both breast cancer
cells tested MDA-MB-231 and MCF7, express low levels
of this receptor [34]. Additionally, it has been suggested
that ERβ exerts anti-proliferative effects in breast cancer
cells in the presence of ERα, but exerts proliferative effects
in the absence of ERα [17]. If this were true, treatment
with PINO would result in an increase of MDA-MB-231
breast cancer cell (ERβ low/ ERα negative) proliferation.
Instead, we found an anti-proliferative effect, which was
even greater than that observed in MCF7 breast tumour
Fig. 6 DCFH-DA assay. Intracellular Reactive Oxygen Species (ROS) in breast cells treated with (+)-pinoresinol (in a range from 0.001 – 100 μM) for
24 h under basal conditions a and after H2O2-induced oxidative stress b. Data are presented as the mean ± SEM of three independent
experiments and *(for MDA-MB-231), † (for MCF7) and Δ (for MCF10A) represent statistically significant differences (p < 0.05) with respect to the
control, which was set as 100 %
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cells (ERβ low/ ERα positive). Based on these results, we
hypothesize that the anti-proliferative effects of PINO in
the breast cancer cells assayed are independent of both
ERα and ERβ status.
Previously, it has been shown that persistent ROS in-
duction in non-tumorigenic cells may lead to cancer ini-
tiation, progression and spreading via activation and
maintenance of signalling pathways that regulate cellular
proliferation, survival, angiogenesis and metastasis [35].
However, we have not found previously published results
regarding the antioxidant capacity of PINO in mammary
cells. Our results suggest that PINO may prevent cancer
development, as it diminished ROS levels in MCF10A
mammary epithelial cells.
On the other hand, it is known that cancer cells possess
higher intracellular ROS levels than non-tumorigenic cells
and that enhanced ROS levels may be exploited to promote
cancer cell death [36]. In fact, many of the commonly used
chemotherapies are based on increasing oxidative stress
above a toxic threshold level to selectively kill cancer cells
[36]. In line with this concept, PINO may be used as a po-
tential effective adjuvant to cancer therapies, as it was
found to promote ROS generation in breast cancer cells,
while it tended to diminish ROS induction in mammary
epithelial cells. MCF7 cells were shown to be particularly
sensitive to increased ROS levels after H2O2-induced oxida-
tive stress, which could be related with the levels of DNA
damage observed under basal conditions and after oxidative
Fig. 7 Comet assay. DNA oxidative damage in MDA-MB-231 a MCF7 b or MCF10A c after (+)-pinoresinol treatments expressed as Olive_TM
(mean ± SEM). The comet assay was performed under basal and H2O2-induced injury conditions. Data are expressed as the percentage relative to
the basal (untreated) control, which was set as 100 %. Statistically significant differences (*, † or Δ) were established relative to basal or H2O2-
treated control (p < 0.05). d Representative comet assay images showing different treatments on MDA-MB-231, MCF7 and MCF10A cells
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shock. Under basal conditions, PINO also caused DNA
damage in MDA-MB-231 cells; however, in contrast, PINO
treatment prevented DNA damage in non-tumorigenic
mammary epithelial cells, suggesting that PINO treatment
may protect DNA in a pro-tumorigenic environment,
thereby inhibiting breast cancer initiation and progression.
Surprisingly, ER negative cells showed reduced DNA dam-
age in response to H2O2, whereas ER positive cells showed
an increase in DNA damage.
Very few reports have studied the chemical antioxidant
capacity of PINO, and the results have varied consider-
ably. For example, Kuo et al. [22] obtained a significant
DPPH free radical scavenging activity for PINO, but these
results differ from the work done by Chin et al. [21] and
Vuorela et al. [23], which demonstrated a much higher
IC50. Our results suggest that PINO harbours a radical
scavenging activity at concentrations of 10 μM or above
for ABTS. This capacity was also shown using the DPPH
method and is line with work published by Chin et al.
[21]. In the ORAC assay, which is considered to be the
most biologically relevant assay [24], PINO also showed
antioxidant activity in a dose dependent manner.
Conclusions
Here, we showed that PINO possesses a chemical anti-
oxidant capacity and may have a therapeutic potential to
prevent breast cancer development via the reduction of
intracellular oxidative stress and DNA damage in human
mammary epithelial cells. Furthermore, we showed that
PINO promotes an increase in the ROS levels of breast
cancer cells after H2O2 treatment. In sum, this work
suggests that PINO may act as adjuvant to pro-oxidative
chemotherapies.
Finally, we showed that PINO has anti-tumour effects
at low concentrations by promoting cytotoxic, anti-
proliferative and pro-oxidant activities in breast cancer
cells, independent of their oestrogen receptor status.
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